The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Abstract
The elucidation of the human genome sequence has made it possible to identify genetic alterations in cancers in unprecedented detail. To begin a systematic analysis of such alterations, we determined the sequence of well-annotated human protein-coding genes in two common tumor types. Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ∼90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention, and open fertile avenues for basic research in tumor biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Self-citationBase-Calling of Automated Sequencer Traces Using Phred. II. Error Probabilities
Ewing, B., & Green, P. (1998) · Genome Research · doi:10.1101/gr.8.3.186 · Cited by 5,439
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationGenetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Self-citationIntegrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050
Prevalence of ras gene mutations in human colorectal cancers
Bos, J. L., Fearon, E. R., Hamilton, S. R., Vries, M. V., van Boom, J. H., van der Eb, A. J., & Vogelstein, B. (1987) · Nature · doi:10.1038/327293a0 · Cited by 1,860
Self-citationLandis, C. A., Masters, S. B., Spada, A., Pace, A. M., Bourne, H. R., & Vallar, L. (1989) · Nature · doi:10.1038/340692a0 · Cited by 1,441
Cited by
Items 301–351 of 351
RAC1 P29S is a spontaneously activating cancer-associated GTPase
Davis, M. J., Ha, B. H., Holman, E. C., Halaban, R., Schlessinger, J., & Boggon, T. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220895110 · Cited by 180
Yeh, J. J., Routh, E. D., Rubinas, T., Peacock, J., Martin, T. D., Shen, X. J., Sandler, R. S., Kim, H. J., Keku, T. O., & Der, C. J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0972 · Cited by 172
Sensitivity analysis methods in the biomedical sciences
Qian, G., & Mahdi, A. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108306 · Cited by 169
Functional Copy-Number Alterations in Cancer
Taylor, B. S., Barretina, J., Socci, N. D., DeCarolis, P., Ladanyi, M., Meyerson, M., Singer, S., & Sander, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003179 · Cited by 170
Transcriptome sequencing of malignant pleural mesothelioma tumors
Sugarbaker, D. J., Richards, W. G., Gordon, G. J., Dong, L., De Rienzo, A., Maulik, G., Glickman, J. N., Chirieac, L. R., Hartman, M.-L., Taillon, B. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712399105 · Cited by 155
Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer
Valle, L., Serena-Acedo, T., Liyanarachchi, S., Hampel, H., Comeras, I., Li, Z., Zeng, Q., Zhang, H.-T., Pennison, M. J., Sadim, M., et al. (2008) · Science · doi:10.1126/science.1159397 · Cited by 141
2-Hydroxyglutarate in Cancer Cells
Ježek, P. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130
Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance
Saddawi-Konefka, R., Seelige, R., Gross, E. T. E., Levy, E., Searles, S. C., Washington, A., Santosa, E. K., Liu, B., O’Sullivan, T. E., Harismendy, O., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.075 · Cited by 126
“Moreover, oncogenic alleles have been shown to induce Nrf2 (DeNicola et al., 2011), and mutations in KEAP1 can be detected in cancer cells, leading to constitutive Nrf2 activation (Padmanabhan et al., 2006; Shibata et al., 2008; Sjoblom et al., 2006).”
LGR6 Is a High Affinity Receptor of R-Spondins and Potentially Functions as a Tumor Suppressor
Gong, X., Carmon, K. S., Lin, Q., Thomas, A., Yi, J., & Liu, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037137 · Cited by 129
“More importantly, LGR6 was found to be one of the commonly mutated genes in a group of colon cancer samples that were sequenced by whole-exon sequencing [17].”
BackgroundInfluentialPP2A Regulates HDAC4 Nuclear Import
Paroni, G., Cernotta, N., Dello Russo, C., Gallinari, P., Pallaoro, M., Foti, C., Talamo, F., Orsatti, L., Steinkühler, C., & Brancolini, C. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0623 · Cited by 126
Osumi, H., Shinozaki, E., Yamaguchi, K., & Zembutsu, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-53711-3 · Cited by 114
Jin, G., Reitman, Z. J., Spasojevic, I., Batinic-Haberle, I., Yang, J., Schmidt-Kittler, O., Bigner, D. D., & Yan, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016812 · Cited by 112
“lymphoblastic leukemia, B type [7], colorectal cancer [8], and melanoma [9].”
BackgroundFinding the tumor copycat: Therapy fails, patients don’t
Ellis, L. M., & Fidler, I. J. (2010) · Nature Medicine · doi:10.1038/nm0910-974 · Cited by 109
The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1
Cullis, J., Meiri, D., Sandi, M. J., Radulovich, N., Kent, O. A., Medrano, M., Mokady, D., Normand, J., Larose, J., Marcotte, R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.025 · Cited by 100
Recurrent inactivating RASA2 mutations in melanoma
Arafeh, R., Qutob, N., Emmanuel, R., Keren-Paz, A., Madore, J., Elkahloun, A., Wilmott, J. S., Gartner, J. J., Di Pizio, A., Winograd-Katz, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3427 · Cited by 107
Self-citationMeeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
“In addition, several PTPRD somatic mutations have been described in CRC, lung cancer, glio- and neuroblastoma, melanoma, HNSCC, esophageal cancer, endometrial cancers, pancreatic SCC and nodal marginal zone lymphoma (206-212).”
BackgroundProperdin: New roles in pattern recognition and target clearance
Kemper, C., & Hourcade, D. E. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.034 · Cited by 95
Wilson, K. E., Li, Y.-W., Yang, N., Shen, H., Orillion, A. R., & Zhang, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534701 · Cited by 92
Altering chemosensitivity by modulating translation elongation
Robert, F., Carrier, M., Rawe, S., Chen, S., Lowe, S., & Pelletier, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005428 · Cited by 90
“oncogenes may be too narrow an approach for drug development, but rather targeting nodes that reside downstream of these pathways may offer broader acting therapies [1,2].”
BackgroundThe genetics of melanoma: recent advances
Hill, V. K., Gartner, J. J., Samuels, Y., & Goldstein, A. M. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153429 · Cited by 86
Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidy
Salem, H., Rachmin, I., Yissachar, N., Cohen, S., Amiel, A., Haffner, R., Lavi, L., & Motro, B. (2010) · Oncogene · doi:10.1038/onc.2010.162 · Cited by 86
Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
Vail, M. E., Murone, C., Tan, A., Hii, L., Abebe, D., Janes, P. W., Lee, F.-T., Baer, M., Palath, V., Bebbington, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0218 · Cited by 83
Pharmacological reactivation of p53 as a strategy to treat cancer
Zawacka‐Pankau, J., & Selivanova, G. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12336 · Cited by 82
Mutation patterns in cancer genomes
Rubin, A. F., & Green, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912499106 · Cited by 80
2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
Yang, Z., Jiang, B., Wang, Y., Ni, H., Zhang, J., Xia, J., Shi, M., Hung, L.-M., Ruan, J., Mak, T. W., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.012 · Cited by 78
The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7
Szalmás, A., Tomaić, V., Basukala, O., Massimi, P., Mittal, S., Kónya, J., & Banks, L. (2017) · Journal of Virology · doi:10.1128/jvi.00057-17 · Cited by 78
Reproducing Statistical Results
Stodden, V. (2015) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-010814-020127 · Cited by 77
Intratumoral Patterns of Genomic Imbalance in Glioblastomas
Nobusawa, S., Lachuer, J., Wierinckx, A., Kim, Y. H., Huang, J., Legras, C., Kleihues, P., & Ohgaki, H. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00395.x · Cited by 75
Rajendran, B. K., & Deng, C.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.17225 · Cited by 73
Leucine Rich Repeat Proteins: Sequences, Mutations, Structures and Diseases
Matsushima, N., Takatsuka, S., Miyashita, H., & Kretsinger, R. H. (2019) · Protein & Peptide Letters · doi:10.2174/0929866526666181208170027 · Cited by 73
Translesion DNA Polymerases and Cancer
Makridakis, N. M., & Reichardt, J. K. V. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00174 · Cited by 70
Reversing the aging stromal phenotype prevents carcinoma initiation
Lewis, D. A., Travers, J. B., Machado, C., Somani, A.-K., & Spandau, D. F. (2011) · Aging · doi:10.18632/aging.100318 · Cited by 66
Lin, Y.-H., Kakadia, P. M., Chen, Y., Li, Y.-Q., Deshpande, A. J., Buske, C., Zhang, K.-L., Zhang, Y., Xu, G.-L., & Bohlander, S. K. (2009) · Blood · doi:10.1182/blood-2009-03-209395 · Cited by 64
Analysis of cytoskeletal and motility proteins in the sea urchin genome assembly
Morris, R. L., Hoffman, M. P., Obar, R. A., McCafferty, S. S., Gibbons, I. R., Leone, A. D., Cool, J., Allgood, E. L., Musante, A. M., Judkins, K. M., et al. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.052 · Cited by 60
The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape
Wang, L.-H., Aberin, M. A. E., Wu, S., & Wang, S.-P. (2021) · Biochemical Society Transactions · doi:10.1042/bst20191164 · Cited by 53
Histone modifications as a pathogenic mechanism of colorectal tumorigenesis
Gargalionis, A. N., Piperi, C., Adamopoulos, C., & Papavassiliou, A. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.002 · Cited by 53
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes
Fordyce, C. A., Patten, K. T., Fessenden, T. B., DeFilippis, R., Hwang, E. S., Zhao, J., & Tlsty, T. D. (2012) · Breast Cancer Research · doi:10.1186/bcr3368 · Cited by 50
Dow, D. J., Huxley-Jones, J., Hall, J. M., Francks, C., Maycox, P. R., Kew, J. N. C., Gloger, I. S., Mehta, N. A. L., Kelly, F. M., Muglia, P., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.009 · Cited by 48
Morozova, O., & Marra, M. A. (2008) · Biochemistry and Cell Biology · doi:10.1139/o08-003 · Cited by 46
Dependence receptors and colorectal cancer
Mehlen, P., & Tauszig-Delamasure, S. (2014) · Gut · doi:10.1136/gutjnl-2013-306704 · Cited by 44
The role of protein acetylation in carcinogenesis and targeted drug discovery
Yang, J., Song, C., & Zhan, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.972312 · Cited by 42
Fordyce, C., Fessenden, T., Pickering, C., Jung, J., Singla, V., Berman, H., & Tlsty, T. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0229 · Cited by 41
Rimmelé, P., Komatsu, J., Hupé, P., Roulin, C., Barillot, E., Dutreix, M., Conseiller, E., Bensimon, A., Moreau-Gachelin, F., & Guillouf, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4691 · Cited by 38
Rajendran, B. K., & Deng, C.-X. (2017) · Oncotarget · doi:10.18632/oncotarget.20404 · Cited by 32
Cancer survival classification using integrated data sets and intermediate information
Kim, S., Park, T., & Kon, M. (2014) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2014.06.003 · Cited by 25
TMEM39A and Human Diseases: A Brief Review
Tran, Q., Park, J., Lee, H., Hong, Y., Hong, S., Park, S., Park, J., & Kim, S.-H. (2017) · Toxicological Research · doi:10.5487/tr.2017.33.3.205 · Cited by 25
“In addition, it has been found that TMEM39A was mutated in breast cancer (32).”
BackgroundGambaro, K., Quinn, M. C., Cáceres-Gorriti, K. Y., Shapiro, R. S., Provencher, D., Rahimi, K., Mes-Masson, A.-M., & Tonin, P. N. (2015) · BMC Cancer · doi:10.1186/s12885-015-1138-8 · Cited by 21
“regulation in breast and colorectal cancers [54], although there is evidence of epigenetic silencing occurring in other types of cancer cell lines [24-26,41].”
BackgroundMethodSequence divergence of Mus spretus and Mus musculus across a skin cancer susceptibility locus
Mahler, K. L., Fleming, J. L., Dworkin, A. M., Gladman, N., Cho, H.-Y., Mao, J.-H., Balmain, A., & Toland, A. E. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-626 · Cited by 18
Non-parametric Survival Analysis of EPG5 Gene with Age at Onset of Alzheimer’s Disease
Wang, K.-S., Liu, X., Xie, C., Liu, Y., & Xu, C. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0821-9 · Cited by 12
S-nitrosoglutathione reductase deficiency increases mutagenesis from alkylation in mouse liver
Leung, J., Wei, W., & Liu, L. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt031 · Cited by 12
Chichester, C., Gaudet, P., Karch, O., Groth, P., Lane, L., Bairoch, A., Mons, B., & Loizou, A. (2014) · Journal of Web Semantics · doi:10.1016/j.websem.2014.05.001 · Cited by 12
Metadata
- Authors
- Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J. K. V., Gazdar, A. F., Hartigan, J., Wu, L., Liu, C., Parmigiani, G., Park, B. H., Bachman, K. E., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., & Velculescu, V. E.
- Venue
- Science
- Published
- 2006-10-13
- Volume
- 314
- Issue
- 5797
- Pages
- 268-274
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4240237951
- Cited by
- 3,169
- References
- 36
- FWCI
- 88.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.